Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Download the PDF here.
This post appeared first on investingnews.com
You may also like
Anteros Metals
Investor Insight Anteros Metals offers investors exposure to a diversified portfolio of critical and base ...
Prismo Metals
Investor Insight Prismo Metals presents a compelling investment opportunity with its strategic focus on high-grade ...